Indian Moxifloxacin Exporters: Complete Supplier Ranking with Market Share — 731 Manufacturers (2026) — TransData Nexus

Q: Who is the largest moxifloxacin buyer importing from India?

NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) is the largest moxifloxacin importer from India with a 42.2% market share and import value of $13.8M.

Q: How many moxifloxacin buyers import from India?

There are 731 active moxifloxacin buyers importing from India, with a combined import market of $32.8M across 2,413 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top moxifloxacin buyers from India?

The top 5 moxifloxacin buyers — NATIONAL TUBERCULOSIS AND LEPROSY, AUROLOGISTICS LLC, (AUROBINDO PHARM, MYLAN INSTITUTIONAL INC 2898, NORTHSTAR DISTRIBUTION CENTER 8912, I+ SOLUTIONS, — together control 49.9% of total moxifloxacin import value from India.

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Market Analysis: Top Importing Countries & Their Importers

1Nigeria

Nigeria emerges as the first largest importing country, achieving a total trade value of $14.7M through 8 shipments. This represents a market share of 44.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Nigeria has a diverse importer base, with their top importers including:

• NATIONAL TUBERCULOSIS AND LEPROSY - $13.8M (94.2% of country's total business)

• MICRO NOVA PHARMACEUTICALS IND - $383.9K (2.6% of country's total business)

Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $1.8M, indicating premium pricing strategy compared to the market average of $13.6K.

Nigeria is a key market for Moxifloxacin imports, representing 44.8% of total trade value.

Primary Market

Secondary Market

2United States

United States emerges as the second largest importing country, achieving a total trade value of $5.8M through 82 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Moxifloxacin buyer market intelligence

1Buyer Segment Analysis

The importers of Moxifloxacin from India can be categorized into several key segments:

1. Government Procurement Agencies: These entities are responsible for national health initiatives and bulk purchasing for public health programs. The largest buyer in this category is the National Tuberculosis and Leprosy Control Programme in Nigeria, accounting for $13.84 million in imports. Their purchasing behavior typically involves large-volume orders aligned with government tenders and health campaigns.

2. Pharmaceutical Distributors: Companies that import and distribute pharmaceuticals to various healthcare providers. Examples include Aurobindo Pharma USA, Inc. ($0.44 million) and Northstar Distribution Center ($0.57 million) in the United States. These distributors often place consistent orders to maintain supply chains for hospitals and pharmacies.

3. Contract Manufacturers: Organizations that import active pharmaceutical ingredients (APIs) or finished products for further processing or packaging. Mylan Institutional Inc. ($0.74 million) in the United States falls into this category. Their purchasing patterns are driven by production schedules and client demands.

4. International Health Organizations: Entities like I+ Solutions in the Netherlands ($0.49 million) procure pharmaceuticals for global health programs. Their orders are often large and periodic, corresponding with specific health initiatives.

5. Retail Chains and Hospital Groups: While not prominently featured among the top buyers, these entities import Moxifloxacin to meet the needs of their patient populations, with purchasing behaviors influenced by local demand and treatment protocols.

Country-Specific Import Regulations

TransData Nexus Moxifloxacin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Moxifloxacin are as follows:

1. Nigeria:

Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

Import Registration Process: Importers must register pharmaceutical products with NAFDAC, which includes submitting a dossier for screening and obtaining a Sample Import Permit. The process involves multiple steps, including business incorporation, trademark registration, and obtaining a Pre-Arrival Assessment Report and Form M. (nigeriainfotrade.fmiti.gov.ng)

Estimated Timeline: The registration process typically takes up to 120 days from the acceptance of the application. (nafdac.gov.ng)

Import Tariff/Duty: Specific tariff information for HS Code 30049099 is not readily available; importers should consult the Nigeria Trade Information Portal for detailed rates. (nigeriainfotrade.fmiti.gov.ng)

2. United States:

Demand Drivers & Market Opportunity

TransData Nexus Moxifloxacin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Moxifloxacin in importing countries is driven by several factors:

1. Disease Prevalence: Moxifloxacin is commonly used to treat respiratory tract infections, including tuberculosis (TB). Countries like Nigeria have high TB prevalence, necessitating substantial procurement of effective antibiotics.

2. Government Healthcare Programs: National health initiatives, such as Nigeria's National Tuberculosis and Leprosy Control Programme, drive significant demand for Moxifloxacin to combat TB.

3. Universal Health Coverage Expansion: Efforts to expand healthcare access in countries like Thailand and France increase the demand for essential medicines, including Moxifloxacin.

4. WHO Essential Medicines List Procurement: Moxifloxacin is listed on the WHO Essential Medicines List, prompting countries to include it in their procurement for public health programs.

5. Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, leading to bulk purchases of Moxifloxacin to meet public health needs.

With 731 buyers across 137 countries, the global demand for Moxifloxacin reflects its critical role in treating bacterial infections and underscores the importance of understanding the diverse buyer landscape and regulatory environments.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Moxifloxacin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest moxifloxacin buyer importing from India?

Based on import volume and value, NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) leads with $13.8M in imports and a 42.2% market share — the highest of any single moxifloxacin importer. AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) are the next largest buyers.

QHow many companies buy moxifloxacin from India?

There are 731 active moxifloxacin buyers importing from India, with a combined market of $32.8M across 2,413 shipments to 137 countries. The top 5 buyers hold 49.9% of total import value, while the remaining 726 buyers handle the other 50.1%.

QWhich countries import the most moxifloxacin from India?

The top importing countries for moxifloxacin from India are Nigeria (44.8%), United States (17.5%), Netherlands (5.1%), Thailand (3.2%), France (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of moxifloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for moxifloxacin from India?

The average import transaction value for moxifloxacin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Moxifloxacin buyer market intelligence

1Buyer Segment Analysis

The importers of Moxifloxacin from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Moxifloxacin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Moxifloxacin are as follows:

1. Nigeria:

Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

Estimated Timeline: The registration process typically takes up to 120 days from the acceptance of the application. (nafdac.gov.ng)

2. United States:

Demand Drivers & Market Opportunity

TransData Nexus Moxifloxacin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Moxifloxacin in importing countries is driven by several factors:

2. Government Healthcare Programs: National health initiatives, such as Nigeria's National Tuberculosis and Leprosy Control Programme, drive significant demand for Moxifloxacin to combat TB.

3. Universal Health Coverage Expansion: Efforts to expand healthcare access in countries like Thailand and France increase the demand for essential medicines, including Moxifloxacin.

4. WHO Essential Medicines List Procurement: Moxifloxacin is listed on the WHO Essential Medicines List, prompting countries to include it in their procurement for public health programs.

5. Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, leading to bulk purchases of Moxifloxacin to meet public health needs.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Moxifloxacin

Moxifloxacin

Who Buys Moxifloxacin from India — 731 Importers Behind a $32.8M Market

Top Moxifloxacin Importers — Ranked by Import Value

Top Moxifloxacin Buyers & Importers

Related Analysis

Need Details?

Moxifloxacin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Moxifloxacin — and from which countries?

Moxifloxacin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Nigeria

2United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Moxifloxacin Buyers & Importers

QWho is the largest moxifloxacin buyer importing from India?

QHow many companies buy moxifloxacin from India?

QWhich countries import the most moxifloxacin from India?

QWhat is the average import order value for moxifloxacin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Netherlands

4Thailand

5France

Analysis Methodology